MedPath

CLIMACTERON INJECTION

CLIMACTERON INJECTION

Discontinued
DIN Number

02061031

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02061031
AIG Number0306416001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA IV)
A
ATC Code
G03EA02 TESTOSTERONE AND ESTROGEN
Product Specifications
Dosage FormLiquid
Route of AdministrationIntramuscular
AHFS Classification68:16.04
Health Canada Classification

ACTIVE INGREDIENTS (3)

ESTRADIOL BENZOATEActive
Strength: 1 MG / ML
Monograph: ESTRADIOL BENZOATE
ESTRADIOL DIENANTHATEActive
Strength: 7.5 MG / ML
Monograph: ESTRADIOL DIENANTHATE
TESTOSTERONE ENANTHATE BENZILIC ACID HYDRAZONEActive
Strength: 150 MG / ML
Monograph: TESTOSTERONE ENANTHATE BENZILIC ACID HYDRAZONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.